Why the study?
Does enalapril reduce mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions (≤0.35)?
Population
n=4,228 asymptomatic patients with reduced left ventricular ejection fractions who were not receiving drug…
Comparison
Enalapril 2.5 to 20 mg per day vs Placebo
Design
RCT, Randomly assigned, Double-blind
Follow-up
averaged 37.4 months
Loading...
Supports enalapril initiation in asymptomatic LVEF ≤0.35 to delay symptomatic HF; extends ACE inhibitor evidence to prevention.
Does enalapril reduce mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions (≤0.35)?
In patients with asymptomatic left ventricular dysfunction, enalapril significantly delays the onset of symptomatic heart failure and reduces heart failure hospitalizations.
A 1992 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: